Leo Phar­ma spend­ing $14M up­front to ac­quire Tim­ber

Leo Phar­ma plans to ac­quire der­ma­tol­ogy biotech Tim­ber Phar­ma­ceu­ti­cals, which is de­vel­op­ing a treat­ment for a rare, ge­net­ic skin dis­ease.

The pri­vate­ly held Dan­ish bio­phar­ma …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER